Skip to main content
TipRanks
Go Ultimate75% OFF

PDS Biotechnology (EU6) Stock Statistics & Valuation Metrics

2 Followers

Total Valuation

PDS Biotechnology has a market cap or net worth of EUR 77.26M. The enterprise value is EUR 38.79M.

Market Cap
EUR 77.26M
Enterprise Value
EUR 38.79M

Share Statistics

PDS Biotechnology has 105,005,430 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
105,005,430
Owned by Insiders
0.80%
Owned by Institutions
6.45%

Financial Efficiency

PDS Biotechnology’s return on equity (ROE) is -3.73 and return on invested capital (ROIC) is -116.55%.

Return on Equity (ROE)
-3.73
Return on Assets (ROA)
-1.13
Return on Invested Capital (ROIC)
-116.55%
Return on Capital Employed (ROCE)
-1.50
Revenue Per Employee
0
Profits Per Employee
-1.64M
Employee Count
21
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of PDS Biotechnology is -1.39. PDS Biotechnology’s PEG ratio is -0.03.

PE Ratio
-1.39
PS Ratio
0.00
PB Ratio
4.14
Price to FCF
-2.27
Price to Operating Cash Flow
-2.93
PEG Ratio
-0.03

Income Statement

In the last 12 months, PDS Biotechnology had revenue of 0 and earned -34.50M in profits. Earnings per share was -0.74.

Revenue
0
Gross Profit
0
Operating Income
-31.54M
Pretax Income
-35.67M
Net Income
-34.50M
EBITDA
-30.30M
Earnings Per Share (EPS)
-0.74

Cash Flow

In the last 12 months, operating cash flow was -19.09M and capital expenditures 1, giving a free cash flow of -19.09M billion.

Operating Cash Flow
-19.09M
Free Cash Flow
-19.09M
Free Cash Flow per Share
-0.27

Dividends & Yields

PDS Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-43.72%
Earnings Yield
-57.37%

Stock Price Statistics

Beta
0.64
52-Week Price Change
3.58%
50-Day Moving Average
0.90
200-Day Moving Average
0.73
Relative Strength Index (RSI)
38.01
Average Volume (3m)
8,848

Important Dates

PDS Biotechnology upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Apr 01, 2027
Ex-Dividend Date
―

Financial Position

PDS Biotechnology as a current ratio of 2.98, with Debt / Equity ratio of 182.94%

Current Ratio
2.98
Quick Ratio
2.98
Debt to Market Cap
0.47
Net Debt to EBITDA
0.32
Interest Coverage Ratio
-5.91

Taxes

In the past 12 months, PDS Biotechnology has paid -1.17M in taxes.

Income Tax
-1.17M
Effective Tax Rate
0.03

Enterprise Valuation

PDS Biotechnology EV to EBITDA ratio is -1.13, with an EV/FCF ratio of -1.49.

EV to Sales
0.00
EV to EBITDA
-1.13
EV to Free Cash Flow
-1.49
EV to Operating Cash Flow
-1.49

Balance Sheet

PDS Biotechnology has EUR 15.25M in cash and marketable securities with EUR 33.52K in debt, giving a net cash position of EUR 15.21M billion.

Cash & Marketable Securities
EUR 15.25M
Total Debt
EUR 33.52K
Net Cash
EUR 15.21M
Net Cash Per Share
EUR 0.14
Tangible Book Value Per Share
EUR 0.19

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for PDS Biotechnology is EUR 4.10, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
EUR 4.10
Price Target Upside
490.93% Upside
Analyst Consensus
Moderate Buy
Analyst Count
2
Revenue Growth Forecast
―
EPS Growth Forecast
35.78%

Scores

Smart Score
7
AI Score
―